Provided by Tiger Trade Technology Pte. Ltd.

Pfizer

28.07
+0.28001.01%
Post-market: 28.080.0100+0.04%19:59 EDT
Volume:37.11M
Turnover:1.04B
Market Cap:159.60B
PE:36.94
High:28.43
Open:27.77
Low:27.66
Close:27.79
52wk High:28.75
52wk Low:23.58
Shares:5.69B
Float Shares:5.64B
Volume Ratio:1.05
T/O Rate:0.66%
Dividend:1.72
Dividend Rate:6.13%
EPS(TTM):0.7599
EPS(LYR):1.36
ROE:5.01%
ROA:5.78%
PB:1.87
PE(LYR):20.57

Loading ...

Pfizer beats earnings estimates, targets US$2.5 billion in additional cost cuts

Bloomberg
·
Aug 05

RBC Capital Remains a Hold on Pfizer (PFE)

TIPRANKS
·
Aug 05

Pfizer: Hold Rating Reaffirmed as COVID Headwinds Persist and 12‑Month Price Target Remains Unchanged at $26

TIPRANKS
·
Aug 05

Dow Jumps Over 900 Points As Crude Oil Falls: Investor Sentiment Improves Further, Fear Index Moves To ‘Greed’ Zone

Benzinga Earnings
·
Aug 05

Analysts Are Bullish on Top Healthcare Stocks: BioNTech SE (BNTX), Pfizer (PFE)

TIPRANKS
·
Aug 05

Pfizer Inc Earnings Call Signals Cautious Optimism

TIPRANKS
·
Aug 05

Dow Jones Top Company Headlines at 7 PM ET: SpaceX Revenue Could Reach $1 Trillion, Elon Musk Says | Paramount's ...

Dow Jones
·
Aug 05

Inspections of 180 New York Buildings Reveal no Structural Problems

Dow Jones
·
Aug 05

SpaceX, Palantir, AMD, Marvell, Caterpillar, Pfizer, and More Stocks That Explain Today's Market

Dow Jones
·
Aug 05

Pfizer's Diversified Drug Portfolio Fuels Growth as COVID Sales Decline

Benzinga Earnings
·
Aug 05

U.S. Stocks on the MOVE-Expeditors International, Waters, Wayfair

Reuters
·
Aug 05

Cboe data shows mixed options sentiment in Pfizer with shares up 2.3%

TIPRANKS
·
Aug 05

J.P. Morgan Keeps Their Hold Rating on Pfizer (PFE)

TIPRANKS
·
Aug 04

Pfizer Raises Fy2026 Revenue Outlook to USD 60.5-62.5 Billion

Reuters
·
Aug 04

CEO Bourla Says with $6-7 Bln it Has Remaining for Business Development Will be "Very Strategic"

THOMSON REUTERS
·
Aug 04

CEO Bourla Says Pfizer Has Placed Its Business Development Bets Already: Conf Call

THOMSON REUTERS
·
Aug 04

Pfizer CEO Says Company Will Maintain Dividend and Resume Dividend Growth After Loss of Exclusivity Period: Conf Call

THOMSON REUTERS
·
Aug 04

Pfizer's Non-COVID Products Show Strong Performance, Solidifying Recovery Momentum

Deep News
·
Aug 04

Pfizer Says Net Cost Savings from Now Expected to Reach $6.7 Billion Through 2029

Reuters
·
Aug 04

Headlands Research Phase 3 Trial Finds Multidose RSVpreF Vaccine Matches Single-Dose Version on Immunogenicity

Reuters
·
Aug 04